Globe Life (NYSE:GL) Releases FY 2025 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 13.450-14.050 for the period, compared to the consensus EPS estimate of 13.580. The company issued revenue guidance of -.

Globe Life Price Performance

Shares of GL stock traded up $0.52 during trading on Wednesday, hitting $122.93. The company had a trading volume of 587,098 shares, compared to its average volume of 551,996. Globe Life has a 52 week low of $38.95 and a 52 week high of $132.00. The stock has a market capitalization of $10.32 billion, a price-to-earnings ratio of 10.40 and a beta of 0.81. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The stock’s 50-day moving average is $112.56 and its two-hundred day moving average is $106.41.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 19.04% and a return on equity of 22.91%. As a group, analysts predict that Globe Life will post 12.32 EPS for the current fiscal year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.78%. The ex-dividend date was Monday, January 6th. Globe Life’s dividend payout ratio (DPR) is currently 8.12%.

Analyst Ratings Changes

A number of brokerages recently weighed in on GL. Keefe, Bruyette & Woods raised their price objective on Globe Life from $135.00 to $137.00 and gave the company an “outperform” rating in a report on Friday, January 10th. Morgan Stanley lifted their price target on shares of Globe Life from $110.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. Raymond James upped their price objective on shares of Globe Life from $160.00 to $188.00 and gave the company a “strong-buy” rating in a research note on Tuesday, October 15th. TD Cowen initiated coverage on shares of Globe Life in a research report on Wednesday, October 9th. They issued a “buy” rating and a $150.00 target price on the stock. Finally, Evercore ISI upgraded shares of Globe Life from an “in-line” rating to an “outperform” rating and upped their price target for the company from $132.00 to $143.00 in a research report on Wednesday, January 8th. Five analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $132.18.

Insider Activity

In other Globe Life news, CMO Jennifer Allison Haworth sold 9,000 shares of the company’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $112.91, for a total value of $1,016,190.00. Following the completion of the transaction, the chief marketing officer now directly owns 13,485 shares in the company, valued at approximately $1,522,591.35. This represents a 40.03 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Frank M. Svoboda sold 13,448 shares of Globe Life stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the sale, the chief executive officer now directly owns 18,948 shares in the company, valued at $2,132,786.88. The trade was a 41.51 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,788 shares of company stock valued at $4,429,779. Insiders own 1.51% of the company’s stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.